Mr. Speaker, it is my understanding that those drugs that are primarily used for certain outbreaks or certain problems that come about, and it could be malaria, HIV-AIDS or whatever, would be added to schedules and those schedules would then be able to move forward.
At this point in time there is a schedule set forth for certain drugs. This is not a broad spectrum of every drug being put on the scale. It is for those that are dealing with specific problems that we see abroad and richer countries like Canada can help. They cannot manufacture those drugs on their own.
In order to forecast what would be added to those schedules in the future, we would have to look at a broader picture of where those problems would come from and what drugs would be applicable. Then there would have to be amendments to those annexes in order to implement any of that. Again, it would have to come back to an amendment to the schedules in order to change any further drugs that would go on those lists.